A combination of weekly pegylated interferon (peginterferon) alpha and daily ribavirin
represents the standard of care for the treatment of chronic hepatitis C according to current …

BACKGROUND & AIMS: Patients with chronic hepatitis C virus (HCV) infection are
frequently treated with a combination of pegylated interferon (peginterferon) and ribavirin …

The combination treatment of peginterferon alpha‐2a (PEG‐IFN alpha‐2a; Pegasys®) plus
ribavirin (RBV) is recommended as a standard care for HCV infections. Side effects and …

Chronic infection with hepatitis C virus (HCV) is a major healthcare problem, affecting an
estimated 170 million people worldwide. Interferon-α has formed the basis of treatment …

BACKGROUND & AIMS: Ribavirin (RBV) combined with either pegylated interferon
(PegIFN) α2a or PegIFNα2b is the standard of care for chronic hepatitis C virus (HCV) …

Background Treatment with peginterferon alfa-2a alone produces significantly higher
sustained virologic responses than treatment with interferon alfa-2a alone in patients with …

In randomized clinical trials, treatment with peginterferon plus ribavirin (RBV) results in a
sustained virological response (SVR) in around half of hepatitis C virus genotype 1‐infected …

BACKGROUND/AIMS: We assessed the effectiveness and safety of an induction dose of
peginterferon alfa-2b (PEG-IFN) plus ribavirin for initial treatment of patients with genotype 1 …

OBJECTIVES This study compared the efficacy and safety of peginterferon alpha-2a 135
μg/wk, peginterferon alpha-2a 180 μg/wk and interferon alpha-2a in patients with chronic …

Background: The efficacy and safety of peginterferon alpha‐2a (40 KD)(peg‐IFNα‐2a) plus
ribavirin has not been reported for Japanese patients with chronic hepatitis C. The aim of …